l-Menthol sprayed on gastric mucosa causes edematous change

Background and study aims: l-Menthol (LM), sprayed on the distal gastric mucosa, is a safe antispasmodic agent used during esophagogastroduodenoscopy (EGD). However, it seems to affect gastric mucosal endoscopic findings. Therefore, we evaluated whether LM causes specific changes and impacts the endoscopic morphology of gastric lesions.

Patients and methods: A total of 98 patients scheduled to undergo EGD were randomly assigned to receive LM solution (160 mg of 0.8 % LM added to 2.5 mL of indigo carmine [IC]; n = 49; LM group) or decuple-diluted IC solution without LM (n = 49; placebo group). We compared the incidence of specific mucosal changes and the difference in the endoscopic findings of several gastric lesions between these groups.

Results: Annular-reticular – like mucosal changes appeared immediately after the administration of LM solution. This change was observed in 71.4 % of the LM group compared with 12.2 % of the placebo group (P < 0.01). In the placebo group, this change was observed in 14.7 % of subjects with atrophic gastritis compared with 6.7 % of those without atrophic gastritis (P = 0.39), whereas in the LM group, this change was observed in 84.8 % of subjects with atrophic gastritis compared with 43.8 % of those without atrophic gastritis (P < 0.01). Most early gastric cancers, erosions, and ulcers observed in this study became well demarcated after LM administration, although the incidence of gastric lesions did not differ significantly between the two groups.

Conclusion: LM changes the gastric mucosa into edematous mucosa, and this occurs more frequently in atrophic gastric mucosa than in pathologic lesions. LM may facilitate the demarcation of pathologic gastric lesions without intestinal metaplasia.

• References

• 1 Leung WK, Wu MS, Kakugawa Y et al. Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol 2008; 9: 279-287
• 2 Hiki N, Kaminishi M, Yasuda K et al. Antiperistaltic effect and safety of L-menthol sprayed on the gastric mucosa for upper GI endoscopy: a phase III, multicenter, randomized, double-blind, placebo-controlled study. Gastrointest Endosc 2011; 73: 932-941
• 3 Hiki N, Kaminishi M, Tanabe S et al. An open-label, single-arm study assessing the efficacy and safety of L-menthol sprayed onto the gastric mucosa during upper gastrointestinal endoscopy. J Gastroenterol 2011; 46: 873-882
• 4 Katoh K, Nomura M, Iga A et al. Comparison of gastric peristalsis inhibition by scopolamine butylbromide and glucagon: evaluation by electrogastrography and analysis of heart rate variability. J Gastroenterol 2003; 38: 629-635
• 5 Hashimoto T, Adachi K, Ishimura N et al. Safety and efficacy of glucagon as a premedication for upper gastrointestinal endoscopy – a comparative study with butyl scopolamine bromide. Aliment Pharmacol Ther 2002; 16: 111-118
• 6 Hiki N, Kurosaka H, Tatsutomi Y et al. Peppermint oil reduces gastric spasm during upper endoscopy: a randomized, double-blind, double-dummy controlled trial. Gastrointest Endosc 2003; 57: 475-482
• 7 Imagawa A, Hata H, Nakatsu M et al. Peppermint oil solution is useful as an antispasmodic drug for esophagogastroduodenoscopy, especially for elderly patients. Dig Dis Sci 2012; 57: 2379-2384
• 8 Hikichi T, Irisawa A, Sato M et al. Utility of peppermint oil for endoscopic diagnosis of gastric tumors. Fukushima J Med Sci 2011; 57: 60-65
• 9 Mori A, Ohashi N, Tatebe N et al. Autonomic nervous function in upper gastrointestinal endoscopy: a prospective randomized comparison between transnasal and oral procedures. J Gastroenterol 2008; 43: 38-44
• 10 Hiki N, Kaminishi M, Yasuda K et al. Multicenter phase II randomized study evaluating dose-response of antiperistaltic effect of L-menthol sprayed onto the gastric mucosa for upper gastrointestinal endoscopy. Dig Endosc 2012; 24: 79-86
• 11 Kaminishi M, Yamaguchi H, Nomura S et al. Endoscopic classification of chronic gastritis based on the results of a pilot study by research society for gastritis. Dig Endosc 2002; 14: 138-151
• 12 Kligler B, Chaudhary S. Peppermint oil. Am Fam Physician 2007; 75: 1027-1030
• 13 Moghadam BK, Gier R, Thurlow T. Extensive oral mucosal ulcerations caused by misuse of a commercial mouthwash. Cutis 1999; 64: 131-134
• 14 Tamir S, Davidovich Z, Attal P et al. Peppermint oil chemical burn. Otolaryngol Head Neck Surg 2005; 133: 801-802
• 15 Parys BT. Chemical burns resulting from contact with peppermint oil mar: a case report. Burns Incl Therm Inj 1983; 9: 374-375
• 16 Leung WK, Sung JJ. Review article: intestinal metaplasia and gastric carcinogenesis. Aliment Pharmacol Ther 2002; 16: 1209-1216
• 17 Hills JM, Aaronson PI. The mechanism of action of peppermint oil on gastrointestinal smooth muscle. An analysis using patch clamp electrophysiology and isolated tissue pharmacology in rabbit and guinea pig. Gastroenterology 1991; 101: 55-65
• 18 Imagawa A, Takeuchi K, Yoshida Y et al. The evaluation of effectiveness and safety of peppermint oil solution as antispasmodic agent during endoscopic submucosal dissection [in Japanese with English abstract]. Gastroenterol Endosc 2012; 54: 3783-3789
• 19 Yagi K, Aruga Y, Nakamura A et al. The study of dynamic chemical magnifying endoscopy in gastric neoplasia. Gastrointest Endosc 2005; 62: 963-969